DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
October 7-8, 1991 
The Recombinant DNA Advisory Committee (RAC) was convened for its forty-seventh 
meeting at 9:00 a.m. on October 7, 1991, in Building 31C, Conference Room 6, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. Gerard J. 
McGarrity (Chair) presided. In accordance with Public Law 92-463, the meeting was 
open to the public. The following were present for all or part of the meeting: 
Committee members: 
Ronald M. Atlas, University of Louisville 
John H. Barton, Stanford Law School 
A1 W. Bourquin, Ecova Italia 
Michael F. Brewer, Dunn and Bradstreet Corporation 
Nancy L. Buc, Weil, Gotshal and Manges 
Alexander M. Capron, University of Southern California 
Ira H. Carmen, University of Illinois 
Roy H. Doi, University of California 
Anna C. Epps, Tulane University 
E. Peter Geiduschek, University of California, San Diego 
Martin F. Gellert, National Institutes of Health 
Robert Haselkorn, University of Chicago 
William N. Kelley, University of Pennsylvania Medical Center 
Brigid G. Leventhal, Johns Hopkins Hospital 
Brian F. Mannix, Buckland Mill Associates 
Gerard J. McGarrity, Coriell Institute for Medical Research 
R. Scott Mclvor, University of Minnesota 
Barbara E. Murray, University of Texas 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Moselio Schaechter, Tufts University 
1 The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific 
issues. 
[ 6 ] 
Recombinant DNA Research, Volume 15 
